 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/13/2017 |
$1.20 |
$1.27 |
$1.15 |
$1.20 |
105.70K | | 09/14/2017 |
$1.20 |
$1.30 |
$1.20 |
$1.25 |
62.20K | | 09/15/2017 |
$1.35 |
$1.35 |
$1.20 |
$1.20 |
86.40K | | 09/18/2017 |
$1.20 |
$1.27 |
$1.15 |
$1.15 |
69.70K | | 09/19/2017 |
$1.20 |
$1.20 |
$1.15 |
$1.15 |
23.60K |
|
|
| ARCA biopharma is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. Co.'s key product candidate, Gencaro™ (bucindolol hydrochloride), is a pharmacological beta-blocker and mild vasodilator that Co. is developing for the treatment of patients with atrial fibrillation, and chronic heart failure with reduced left ventricular ejection fraction. Co. also has pharmacogenetic and other patent rights to drug candidates that have potential indications in cardiovascular disease, oncology and other therapeutic areas, in both early and later stages of development. |
|
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on September 13, 2017, ABIO opened at $1.20, traded as high as $1.27 and as low as $1.15, and closed at $1.20. Trading volume was a total of 105.70K shares. On September 14, 2017, ABIO opened at $1.20, traded as high as $1.30 and as low as $1.20, and closed at $1.25. Trading volume was a total of 62.20K shares. On September 15, 2017, ABIO opened at $1.35, traded as high as $1.35 and as low as $1.20, and closed at $1.20. Trading volume was a total of 86.40K shares. On September 18, 2017, ABIO opened at $1.20, traded as high as $1.27 and as low as $1.15, and closed at $1.15. Trading volume was a total of 69.70K shares. On September 19, 2017, ABIO opened at $1.20, traded as high as $1.20 and as low as $1.15, and closed at $1.15. Trading volume was a total of 23.60K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/20/2007 |
|
| End date: |
09/19/2017 |
|
| Start price/share: |
$1,755.60 |
|
| End price/share: |
$1.15 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.93% |
|
| Average Annual Total Return: |
-51.94% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6.55 |
|
| Years: |
10.01 |
|
|
|
| Date |
Close |
| 09/13/2017 | $1.20 | | 09/14/2017 | $1.25 | | 09/15/2017 | $1.20 | | 09/18/2017 | $1.15 | | 09/19/2017 | $1.15 |
|
|
